Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BG8468185Aexternal-prioritypatent/BG41728A1/xx
Application filed by Tpo PharmachimfiledCriticalTpo Pharmachim
Publication of HUT39737ApublicationCriticalpatent/HUT39737A/hu
Publication of HU200449BpublicationCriticalpatent/HU200449B/hu
Forma a de citrato cristalino de 5-(2,4-diamino-pirimidin-5-iloxi)-4-isopropil-2-metoxibenzenossulfonamida, bem como sua composição farmacêutica e usos
Sal de citrato de 11-(2-pirrolidin-1-il-etóxi)-14,19-dioxa5,7,26-triaza-tetraciclo [19.3.1.1(2,6).1 (8,12)]heptacosa1(25),2(26),3,5,8,10,12(27),16,21,23-decaeno, composição farmacêutica compreendendo este e uso deste